On July 21, 2026, the federal government announced a significant pause in Medicaid payments to two states, California and Minnesota, due to concerns over potential fraud and noncompliance. Health Secretary Robert F. Kennedy Jr. stated that the administration is withholding approximately $867 million from California and $199 million from Minnesota. This decision follows advanced analytics and financial investigations that revealed suspicious activities, including billing for services rendered to deceased individuals and for care provided over a year ago. The administration emphasized the need for the states to provide documentation proving the legitimacy of these payments before any funds are released.
The Centers for Medicare and Medicaid Services (CMS) has been actively monitoring Medicaid spending, particularly focusing on in-home services in California, which have seen a 24 percent increase in spending in recent years, significantly higher than the national average. Dr. Mehmet Oz, the CMS administrator, highlighted the importance of ensuring that federal funds are directed towards legitimate healthcare services for real patients. The scrutiny of Medicaid spending is part of a broader effort by the Trump administration to combat fraud, waste, and abuse in federal health programs.
In addition to the withheld funds, the administration is also looking into other questionable spending practices identified by the Minnesota legislative auditor, which has flagged 14 areas as high risk for fraud. The governors of both states, Tim Walz of Minnesota and Gavin Newsom of California, have criticized the administration's actions, labeling them as politically motivated stunts rather than genuine efforts to address fraud. This situation has raised concerns among healthcare providers and patients who rely on Medicaid for essential services.
The Trump administration's focus on combating healthcare fraud has led to significant legal actions, with federal prosecutors recently charging 455 individuals, including 90 medical professionals, for their involvement in fraudulent activities related to healthcare and opioid abuse. The administration's commitment to addressing these issues reflects a growing concern over the integrity of federal health programs and the need to protect taxpayer dollars. As the situation unfolds, the impact on Medicaid recipients and healthcare providers in California and Minnesota remains to be seen, with many stakeholders awaiting further developments regarding the release of the paused funds.
